Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment Medical Dialogues Bureau12 April 2020 8:24 AM GMTNew York: U.S. drugmaker Pfizer Inc said on Thursday that early data has helped it identify a drug candidate with the potential to help treat patients...
Pfizer receives European approval for Oncology Biosimilar, RUXIENCE (rituximab) Medical Dialogues Bureau5 April 2020 8:45 AM GMTNew York: Pfizer Inc. has announced that the European Commission (EC) has approved RUXIENCE™ (rituximab), a monoclonal antibody (mAb) and biosimilar...
USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema Medical Dialogues Bureau29 March 2020 5:57 AM GMTAD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects
Mylan, Pfizer Upjohn merger gets delayed in light on coronavirus Medical Dialogues Bureau28 March 2020 8:00 AM GMTHertfordshire & Pittsburgh: Mylan N.V. and Pfizer Inc. today announced that due to the unprecedented circumstances surrounding the COVID-19...
Pfizer announces positive results from phase 3 study of 20-valent pneumococcal conjugate vaccine Medical Dialogues Bureau22 March 2020 3:30 AM GMTNew York: Pfizer Inc. has announced top-line results from one of its Phase 3 studies, which evaluated the safety and immunogenicity of its 20-valent...
Pfizer, Biontech join hands to co-develop mRNA-based coronavirus vaccine Medical Dialogues Bureau19 March 2020 5:30 AM GMTNew York & Mainz: Pfizer Inc.and BioNTech SE has announced that the companies have agreed to a letter of intent regarding the co-development and...
USFDA accepts regulatory submission for tanezumab for management of chronic pain due to osteoarthritis Medical Dialogues Bureau7 March 2020 4:30 AM GMTTanezumab is a monoclonal antibody that is part of an investigational class of non-opioid chronic pain medications known as nerve growth factor (NGF)...
Sanjeev Narula CFO Pfizer Upjohn appointed as incoming CFO of Viatris Medical Dialogues Bureau28 Feb 2020 8:15 AM GMTViatris is the new company that will result from the planned combination of Mylan and Upjohn
More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs Medical Dialogues Bureau2 Jan 2020 9:18 AM GMTNew Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 4:15 AM GMTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
Pfizer, Novartis lead USD 2 billion spending spree on gene therapy production Medical Dialogues Bureau28 Nov 2019 3:30 AM GMTNew Delhi: Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018,...
Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions Farhat Nasim20 Nov 2019 7:14 AM GMTNew Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
